Literature DB >> 26614705

Chemotherapy in Children with Head and Neck Cancers: Perspectives and Review of Current Therapies.

Daniel K Choi1, Mary Lou Schmidt2.   

Abstract

Cancers of the head and neck in children represent a heterogeneous group of malignancies requiring a variety of treatment modalities. In many instances of childhood head and neck cancers, chemotherapy will be required for treatment, often in conjunction with surgery and/or radiation therapy. Chemotherapy in children with head and neck cancers poses unique challenges in terms of immediate as well as long-term toxicities. This article focuses on the common chemotherapeutic agents, with a particular focus on early and late effects, used in the treatment of children with head and neck cancers.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Lymphoma; Neuroblastoma; Pediatric cancer; Retinoblastoma; Rhabdomyosarcoma

Mesh:

Substances:

Year:  2016        PMID: 26614705     DOI: 10.1016/j.coms.2015.08.004

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  1 in total

1.  Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Authors:  Connie Duong; Sakiko Yoshida; Cathy Chen; Gustavo Barisone; Elva Diaz; Yueju Li; Laurel Beckett; Jong Chung; Reuben Antony; Jan Nolta; Nitin Nitin; Noriko Satake
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.